Active substance
Results for the substance nivolumab
5 results
About this active substance
Nivolumab is an immunotherapy drug used to treat various types of cancer, including melanoma, lung cancer, and kidney cancer. It is a monoclonal antibody that blocks the PD-1 protein, allowing the immune system to recognize and attack cancer cells.
The medication is administered via intravenous infusion and is typically used in cases where other treatments have failed. Nivolumab can extend patient survival and reduce tumor size in certain types of cancer.
Common side effects include fatigue, skin rash, diarrhea, and nausea. In rare cases, it may cause severe autoimmune reactions that require immediate medical attention.
It is important for patients to be closely monitored during treatment. Consult your doctor to discuss the benefits and risks of using Nivolumab.
The medication is administered via intravenous infusion and is typically used in cases where other treatments have failed. Nivolumab can extend patient survival and reduce tumor size in certain types of cancer.
Common side effects include fatigue, skin rash, diarrhea, and nausea. In rare cases, it may cause severe autoimmune reactions that require immediate medical attention.
It is important for patients to be closely monitored during treatment. Consult your doctor to discuss the benefits and risks of using Nivolumab.
-
-
OPDIVO 10mg/ml concentrate for solution for infusion BRISTOL MYERS SQUIBB ORIGINAL MEDICINE
-
OPDIVO 10mg/ml concentrate for solution for infusion BRISTOL MYERS SQUIBB ORIGINAL MEDICINE
-
OPDIVO 300mg solution for injection BRISTOL MYERS SQUIBB ORIGINAL MEDICINE
-
OPDIVO 600mg solution for injection BRISTOL MYERS SQUIBB ORIGINAL MEDICINE